Adjusting the schedule based on tolerance The schedule above is a template, not a rigid prescription
The disease, which, according to the FDA, affects one in every 40,000 people in the U.S., is characterized by loss of motor and cognitive function and early death
Also, if there is no clinical data for a substance, and an awareness that the substance has the propensity for harm, that could make it an appropriate placement on the Category 2 list. Are They Safe
Another point that I pay close attention to is BIOCROWNs certification and compliance history
Cancers Achilles heel: apoptosis and necroptosis to the rescue
Westfall S, Lomis N, Prakash S (2018) Longevity extension in Drosophila through gut-brain communication